Skip to content
OpenCapital
Get started

Oric Pharmaceuticals, Inc. ORIC R&D

R&D at other companies

ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$37.62M-38.6%
CG Oncology logo
CG OncologyCGON
$43.73M+59.2%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
$49.23M+60.8%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$25.22M-31.6%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$39.67M+21.4%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$122M0.0%

Other financials

Income statement

See full
Operating income-$39.6M-21.1%
Net income-$35.8M-19.1%
EPS (diluted)-$0.34+19.0%

Balance sheet

See full
Cash & equivalents$56.4M+14.3%
Total debt$3.3M+2.6%
Total equity$415.6M+89.1%
Total assets$436.8M+79.8%

Cash flow

See full
Operating cash flow-$32.4M+0.3%
CapEx$2.0K-99.5%
Free cash flow-$32.4M+1.5%

Valuation

See full
Market cap$976.17M+23.0%
Enterprise value$923.07M+23.5%

Returns & leverage

See full
Return on equity-42.6%-4.6pp
Debt / equity0×0.0×
Current ratio16.3×+4.3×

Where this comes from

Reported directly by Oric Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.

The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oric Pharmaceuticals, Inc.'s r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oric Pharmaceuticals, Inc.'s R&D?
Oric Pharmaceuticals, Inc. (ORIC) reported R&D of $31.44M in Q1 2026.
How has Oric Pharmaceuticals, Inc.'s R&D changed year-over-year?
Oric Pharmaceuticals, Inc.'s R&D increased by 27.6% year-over-year, from $24.64M to $31.44M.
What is the long-term trend for Oric Pharmaceuticals, Inc.'s R&D?
Over 4 years (2021 to 2025), Oric Pharmaceuticals, Inc.'s R&D has grown at a 17.9% compound annual growth rate (CAGR), from $56.86M to $109.82M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.